11/7/25 16:09 | 11/5/25 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Lewis Joel | GA | DO | P,CEO | M.d | 0 | 2.39 | 0 | 0 | 0 | 835 | D | | | | | | | | | | | | | | |
11/7/25 16:09 | 11/5/25 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Lewis Joel | GA | DO | P,CEO | S.d | -1 | 6.00 | 0 | 0 | 0 | 835 | D | | | | | | | | | | | | | | |
11/5/25 16:06 | 11/3/25 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Lewis Joel | GA | DO | P,CEO | M.dm | 38 | 2.39 | 0 | 16 | 2 | 835 | D | | | | | | | | | | | | | | |
11/5/25 16:06 | 11/3/25 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Lewis Joel | GA | DO | P,CEO | S.dm | -95 | 6.07 | 0 | -16 | -2 | 835 | D | | | | | | | | | | | | | | |
9/15/25 12:45 | 9/12/25 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Lewis Joel | GA | DO | P,CEO | M.d | 33 | 2.39 | 0 | 14 | 2 | 835 | D | | | | | | | | | | | | | | |
9/15/25 12:45 | 9/12/25 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Lewis Joel | GA | DO | P,CEO | S.d | -89 | 6.36 | 0 | -14 | -2 | 835 | D | | | | | | | | | | | | | | |
12/26/24 08:18 | 12/23/24 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Lewis Joel | GA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 56 | 7 | 899 | D | | | | | | | | | | | | | | |
12/26/24 08:18 | 12/23/24 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Lewis Joel | GA | DO | P,CEO | S.d | -50 | 0.8859 | 0 | -56 | -6 | 899 | D | | | | | | | | | | | | | | |
4/25/24 13:27 | 4/24/24 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Lewis Joel | GA | DO | P,CEO | P | 3 | 3.39 | 0 | 1 | 0 | 899 | I | | | | | | | | | | | | | | |
2/21/23 08:31 | 2/16/23 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Lewis Joel | GA | DO | P,CEO | P | 2 | 1.52 | 0 | 1 | 0 | 888 | I | | | | | | | | | | | | | | |